See analyst estimates and all valuation multiples for Bioindustrials
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $36.3B | 1.4x | 6.8x | |
| $17.7B | 4.0x | 16.3x | |
| $13.7B | 2.3x | 6.0x | |
| $11.3B | 0.8x | 5.3x | |
| $10.1B | 4.7x | 10.9x | |
| $10.1B | 3.4x | 9.3x | |
| $7.8B | 1.9x | 8.7x | |
| $6.5B | 3.1x | 9.3x | |
| $5.9B | 6.3x | 22.9x | |
| $2.6B | 0.7x | -356.1x | |
| $2.5B | 0.6x | 4.2x | |
| $1.7B | 1.9x | 11.4x | |
| $1.6B | 1.2x | 8.2x | |
| $1.2B | 2.4x | n/a | |
| $1.2B | 3.5x | 16.6x | |
| $539M | 0.5x | n/a | |
| $523M | 1.3x | 8.8x | |
| $396M | 1.3x | 8.2x | |
| $351M | 1.4x | 10.3x | |
| $311M | 0.6x | 2.1x | |
| $299M | 0.5x | 6.8x | |
| $177M | 2.9x | -3.8x | |
| $75.9M | 13.8x | -0.4x | |
| $61.5M | 569.1x | -11.2x | |
| $59.8M | 5.8x | 96.8x | |
| $32.2M | 7.6x | n/a | |
| $25.8M | n/a | n/a | |
| $22.8M | 1.6x | -3.6x | |
| $12.7M | 2.2x | -7.8x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Bioindustrials